Omada Health (NASDAQ: OMDA) CAO in same-day option exercise and share sale

Rhea-AI Filing Summary

Omada Health, Inc. Chief Accounting Officer Craig Gracey reported a corrected insider transaction reflecting a same-day option exercise and share sale. The amended filing adds an exercise of 2,083 shares of common stock at $6.57 per share and the corresponding sale of 2,083 shares at $18.00 per share. Following the sale, Gracey directly holds 15,441 shares of common stock and a stock option position showing 41,667 option shares outstanding. The transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026.

Insider Trade Summary 10b5-1

Net Seller: 2,083 shares ($37,494)

Net Sell 3 txns

Insider Gracey Craig

Role Chief Accounting Officer

Sold 2,083 shs ($37K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	2,083	$0.00	--
Exercise	Common Stock	2,083	$6.57	$14K
Sale	Common Stock	2,083	$18.00	$37K

Holdings After Transaction: Stock Option (Right to Buy) — 41,667 shares (Direct, null); Common Stock — 17,524 shares (Direct, null)

Footnotes (1)

1. This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Key Figures

Shares sold: 2,083 shares Sale price: $18.00 per share Options exercised: 2,083 shares +3 more

6 metrics

Shares sold 2,083 shares Common stock sold in open-market transaction on June 22, 2026 at $18.00

Sale price $18.00 per share Price for 2,083 Omada Health common shares sold June 22, 2026

Options exercised 2,083 shares Common stock acquired via option exercise coded M on June 22, 2026

Exercise price $6.57 per share Stock option exercise price for 2,083 underlying Omada Health shares

Shares held after 15,441 shares Direct Omada Health common stock holdings following the sale transaction

Options outstanding 41,667 option shares Stock options shown as outstanding after the option exercise transaction

Key Terms

Form 4/A, same-day exercise-and-sale transaction, 10b5-1 trading plan, Vesting Commencement Date, +1 more

5 terms

Form 4/A regulatory

"This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026"

Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.

same-day exercise-and-sale transaction financial

"The exercise reported herein was part of a same-day exercise-and-sale transaction"

10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"

A 10b5-1 trading plan is a pre-arranged strategy that allows company insiders to buy or sell company stock at set times, regardless of their current knowledge about the company's situation. It acts like a scheduled appointment for trading, helping prevent the appearance of impropriety or insider trading. This plan provides a way for insiders to sell or buy shares in a controlled, transparent manner, offering reassurance to investors about fair trading practices.

Vesting Commencement Date financial

"measured from September 9, 2024 (the "Vesting Commencement Date")"

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

Chief Accounting Officer financial

"Gracey Craig serves as Chief Accounting Officer of Omada Health, Inc."

A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/08/2026 - 08:19 PM Accepted by SEC EDGAR 07/08/2026 - 08:19 PM Learn about SEC filing dates

FAQ

What insider transactions did Omada Health (OMDA) report for Craig Gracey?

Omada Health reported that Chief Accounting Officer Craig Gracey exercised 2,083 options at $6.57 and sold 2,083 shares of common stock at $18.00 per share. This was a same-day exercise-and-sale transaction under a pre-arranged 10b5-1 trading plan.

Why was this Omada Health (OMDA) Form 4/A filing amended?

The Form 4/A was filed to correct an omission in the original Form 4. The earlier filing reported the share sale but missed the option exercise, which understated the amount of securities beneficially owned after the transaction.

How many Omada Health (OMDA) shares does Craig Gracey hold after the transaction?

After the reported transactions, Craig Gracey holds 15,441 shares of Omada Health common stock directly. The derivative table also shows a stock option position covering 41,667 shares following the exercise of 2,083 option shares on June 22, 2026.

At what prices did Craig Gracey transact Omada Health (OMDA) shares?

Craig Gracey exercised options for 2,083 shares at an exercise price of $6.57 per share and sold 2,083 shares of common stock at $18.00 per share. Both transactions occurred on June 22, 2026.

Was the Omada Health (OMDA) insider trade under a Rule 10b5-1 plan?

Yes. The filing states the transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Craig Gracey on March 13, 2026. Such plans pre-schedule trades, making the timing more routine and less discretionary.

What are the vesting terms of Craig Gracey’s Omada Health (OMDA) stock option?

The option vests 25% on the first anniversary of the September 9, 2024 vesting commencement date. The remaining shares vest in 1/48th monthly installments, so the grant becomes fully vested on the fourth anniversary of that date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gracey Craig

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
06/24/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/22/2026		M(1)		2,083	A	$6.57	17,524	D
Common Stock	06/22/2026		S(2)		2,083	D	$18	15,441(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$6.57	06/22/2026		M(1)			2,083	(3)	10/23/2034	Common Stock	2,083	$0	41,667	D

Explanation of Responses:

1. This Form 4/A restates in its entirety the original Form 4 filed on 6/24/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

2. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

3. 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

	/s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey	07/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)